Who has invested in Vantis Vascular?

National Institutes of Health are named among the investors backing Vantis Vascular.

Vantis Vascular Funding: $30M Raised, Series B (2024)

Vantis Vascular funding overview

Vantis Vascular is based in San Jose, CA. Vantis Vascular has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2024. The round record for Vantis Vascular runs through 2024; nothing later has been disclosed. Investors on record include National Institutes of Health.

Vantis Vascular at a glance

Total raised: $30M
Latest round: Series B
Latest round date: December 2024
Headquarters: San Jose, CA
Notable investors: National Institutes of Health

Frequently asked about Vantis Vascular funding

How much has Vantis Vascular raised?: Vantis Vascular has raised $30M in total disclosed funding across the rounds on record.
Who has invested in Vantis Vascular?: National Institutes of Health are named among the investors backing Vantis Vascular.
What was the latest Vantis Vascular funding round?: The most recent disclosed round is a Series B, announced in December 2024.
Where is Vantis Vascular based?: Vantis Vascular is based in San Jose, CA.
When did Vantis Vascular last raise?: The last disclosed Vantis Vascular round closed in December 2024 at Series B.

Vantis Vascular totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Jose below to benchmark round size and investor mix.

Vantis Vascular Funding: $30M Raised, Series B (2024)

Vantis Vascular funding overview

Vantis Vascular at a glance

Frequently asked about Vantis Vascular funding

Companies related to Vantis Vascular (23)

Browse related funding lists (3)